<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:ifp="http://www.ifactory.com/press" ifp-element-xpath="/*[local-name() = 'urlset' and namespace-uri() = 'http://www.sitemaps.org/schemas/sitemap/0.9']"><ifp:contentType>ARTICLE</ifp:contentType><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-p714.xml</sm:loc><ifp:title>Venous Thromboembolic Disease</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-p714.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Venous Thromboembolic Disease</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-p707.xml</sm:loc><ifp:title>Does Use of the Adjuvant! Model Influence Use of Adjuvant Therapy Through Better Risk Communication?</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-p707.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Does Use of the Adjuvant! Model Influence Use of Adjuvant Therapy Through Better Risk Communication?</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-p696.xml</sm:loc><ifp:title>Will Risk Evaluation and Mitigation Strategies Ever Be Accepted?</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-p696.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Will Risk Evaluation and Mitigation Strategies Ever Be Accepted?</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-p691.xml</sm:loc><ifp:title>The Fifth “C” Is Cost: Highlights From ASCO 2011</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-p691.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>The Fifth “C” Is Cost: Highlights From ASCO 2011</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-pxxxvi.xml</sm:loc><ifp:title>Oncology Research Program</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-pxxxvi.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Oncology Research Program</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-pxviii.xml</sm:loc><ifp:title>NCCN News</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-pxviii.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>NCCN News</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-pxxxiii.xml</sm:loc><ifp:title>Erratum</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-pxxxiii.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Erratum</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-p781.xml</sm:loc><ifp:title>Heparin-Induced Thrombocytopenia in Cancer</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-p781.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Heparin-Induced Thrombocytopenia in Cancer</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-p800.xml</sm:loc><ifp:title>Risk Stratification for Acute Pulmonary Embolism</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-p800.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Risk Stratification for Acute Pulmonary Embolism</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-p789.xml</sm:loc><ifp:title>Risk Assessment and Prophylaxis for VTE in Cancer Patients</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/9/7/article-p789.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Risk Assessment and Prophylaxis for VTE in Cancer Patients</ifp:title></sm:url></urlset>
